Literature DB >> 10528043

Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis.

R M Du Bois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10528043     DOI： 10.1056/NEJM199910213411710

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.

Authors:  J Britton
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis.

Authors:  Min Huang; Sherven Sharma; Li X Zhu; Michael P Keane; Jie Luo; Ling Zhang; Marie D Burdick; Ying Q Lin; Mariam Dohadwala; Brian Gardner; Raj K Batra; Robert M Strieter; Steven M Dubinett
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 3.  Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.

Authors:  G A W Rook; V Adams; J Hunt; R Palmer; R Martinelli; L Rosa Brunet
Journal:  Springer Semin Immunopathol       Date:  2003-10-08

Review 4.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.

Authors:  Mehrnaz Gharaee-Kermani; Margaret R Gyetko; Biao Hu; Sem H Phan
Journal:  Pharm Res       Date:  2007-03-01       Impact factor: 4.580

5.  EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.

Authors:  Ying Ji Li; Arata Azuma; Jiro Usuki; Shinji Abe; Kuniko Matsuda; Toshiaki Sunazuka; Takako Shimizu; Yukiyo Hirata; Hirofumi Inagaki; Tomoyuki Kawada; Satoru Takahashi; Shoji Kudoh; Satoshi Omura
Journal:  Respir Res       Date:  2006-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.